Neurological research on learning contributed to both the genesis and proliferation of the differentiation theory.
Not exact matches
Many pharmaceutical companies continue to work
on treatments for
neurological diseases, as do many smaller biotech firms and academic medical
research centers, and funding sources for these pursuits include private foundations as well as governments.
Even with the addition of a video and keeping this story
on the front page all weekend, she STILL makes the logical mistake of saying «here is what I have decided is the reality of the situation» (a reality which is HEAVILY debatable, especially in light of recent
neurological research) and then went looking for whatever philosophy was the closest match for her preconceived determination of reality.
They've certainly not been focusing
on the cutting - edge
neurological and psychological
research that Toronto - born journalist Paul Tough surveys in his remarkable — and remarkably hopeful — book How Children Succeed.
Neurological dynamics, and biological responses to trauma perception are
on the forefront of much of the trauma
research today.
Research has found that exposure to lead can have adverse
neurological and cognitive effects
on children.
And its Defense Sciences Office (DSO) has aligned with President Barack Obama's Brain
Research through Advancing Innovative Neurotechnologies Initiative, calling for grant applications
on projects to design therapeutic devices for
neurological disorders and to repair brain damage in military service members.
To date, the only animal
research on the
neurological effects of space radiation has been done in rodents.
Lasmézas»
research focuses
on neurological disorders caused by misfolded proteins, such as Alzheimer's, Parkinson's, prion diseases, frontotemporal dementia and amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
Additional
research funds were provided by the NIH Office of Dietary Supplements; the National Center for Complementary and Integrative Health; the National Institute
on Aging; the National Heart, Lung, and Blood Institute; and the National Institute of
Neurological Disorders and Stroke.
Research on lab animals has shown some of the chemicals cause cancerous tumors and damage developing brain cells, and some can alter hormones essential to reproductive and
neurological development.
The
research focus within the medical community has increasingly centered
on the human intestine and its bacterial population, the so - called microbiome, especially in
neurological disorders such as multiple sclerosis.
Pozzo - Miller reflects that this new
research on LM22A - 4, combined with prior studies from the Katz lab, provides hope that at least some
neurological and cognitive deficits in individuals with Rett could be improved by pharmacological treatment even after the onset of symptoms.
Other funding for the
research was provided by grants from the National Institute
on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute of
Neurological Disorders and Stroke (NINDS).
«This bench to bedside
research is very exciting and will have a major impact on the management of neurological diseases, particularly neuropathic pain,» said Akbar Panju, medical director of the Michael G. DeGroote Institute for Pain Research and Care, a clinician and professor of m
research is very exciting and will have a major impact
on the management of
neurological diseases, particularly neuropathic pain,» said Akbar Panju, medical director of the Michael G. DeGroote Institute for Pain
Research and Care, a clinician and professor of m
Research and Care, a clinician and professor of medicine.
Targeting conclusions that are closer to fiction than science, both Fine and Jordan - Young highlight exaggerations, unreplicated claims, and other silliness from
research on neurological differences between the human sexes.
New
research from University of Liverpool scientists has cast doubt
on the theory that
neurological behaviour is a product of culture in people of Chinese origin.
Specifically, the
research team found that the experimental drug CX456, part of the AMPAkine class in clinical trials for several
neurological conditions, counters for the dampening effect of anesthesia
on nerve signaling.
Research by a Barrow
Neurological Institute neurosurgery team
on novel imaging technique assessment of patients with lumbar spine degeneration was published in the Aug. 28 issue of PLOS ONE.
So far,
research has focused mainly
on how signals from the gut can affect
neurological functions, including some neurodegenerative diseases.
Dr. Palop's
research focuses
on understanding the neural processes underlying cognitive decline in Alzheimer's disease (AD) and in
neurological conditions associated with destabilization of neuronal networks, such as epilepsy, autism, or schizophrenia.
The
research was supported in part by four institutes of the National Institutes of Health — the National Institute
on Drug Abuse, the National Institute of Mental Health, the National Institute of
Neurological Disorders and Stroke, and the National Institute
on Aging.
Neurological research at Gladstone focuses
on a host of devastating conditions, including Alzheimer's, frontotemporal dementia (FTD), Parkinson's and Huntington's disease, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and multiple sclerosis.
Kessler Foundation
Research Center focuses
on improving function and quality of life for persons with injuries of the spinal cord and brain, stroke, multiple sclerosis, and other chronic
neurological conditions.
His
research is based
on the concept that normal brain aging and the pathogeneses of sporadic
neurological diseases are not a consequence of a few single or «disease - specific «factors alone, rather they are driven by holistic events that include one's individual genetic and epigenetic condition, progression of aging, and lifestyle.
The 19 NIH institutes, centers and offices contributing to the Knockout Mouse Project are: the NIH Office of Strategic Coordination / Common Fund; NCRR; the National Eye Institute; NHGRI; the National Institute of Allergy and Infectious Diseases; the National Heart, Lung and Blood Institute; the National Institute
on Aging; the National Institute of Alcohol Abuse and Alcoholism; the National Institute of Arthritis and Musculoskeletal and Skin Diseases; the Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIDCD; the National Institute of Dental and Craniofacial
Research; the National Institute of Environmental Health Sciences; the National Institute of General Medical Sciences; the National Institute of Mental Health; the National Institute of
Neurological Disorders and Stroke; the National Institute of Diabetes and Digestive and Kidney Diseases; the National Cancer Institute; and the Office of AIDS
Research.
The findings, published today in the online journal PloS One, open new opportunities for gaining a greater understanding of Alzheimer's disease and other
neurological diseases and for developing therapies to halt its progression, according to senior author Karen E. Duff, PhD, professor of pathology (in psychiatry and in the Taub Institute for
Research on Alzheimer's Disease and the Aging Brain) at CUMC and at the New York State Psychiatric Institute.
The 19 NIH institutes, centers and offices contributing to the contracts are: National Center for Complementary and Alternative Medicine, National Center for
Research Resources, National Eye Institute, National Human Genome
Research Institute, National Heart, Lung and Blood Institute, National Institute
on Aging, National Institute of Alcohol Abuse and Alcoholism, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Child Health and Human Development, National Institute
on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial
Research, National Institute
on Drug Abuse, National Institute of Environmental Health Sciences, National Institute of General Medical Sciences, National Institute of Mental Health, National Institute of
Neurological Disorders and Stroke, National Institute of Nursing
Research, and the Office of AIDS
Research.
Research focuses
on improving function and quality of life for persons with injuries of the spinal cord and brain, stroke, multiple sclerosis, and other chronic
neurological conditions.
Dr. Landis joined the National Institute of
Neurological Disorders and Stroke in 1995 as Scientific Director and worked to re-engineer the lnstitute's intramural
research program, and fostered the growth of a trans - NIH neuroscience community that led to the construction of the Porter Neuroscience Building
on the NIH campus.
Funding was provided by the National Institute of
Neurological Disorders and Stroke, Taube / Koret Center for Neurodegenerative Disease, Hellman Family Foundation Alzheimer's Disease
Research Program, UCSF Medical Scientist Training Program, Hereditary Diseae Foundation, CHDI Foundation, and the National Institute
on Aging.
Many of our neurologists are supported by grants from the National Institutes of Health for their basic
research work
on various
neurological diseases, including Parkinson's disease, stroke, multiple sclerosis, ALS, and peripheral neuropathy.
He also held several positions of increasing leadership at Praecis Pharmaceuticals, including Director of Cell Biology, where he initiated or contributed to the establishment of numerous
research projects focusing
on the discovery of novel therapeutics for the treatment of cancer, inflammation, infectious disease, and
neurological disorders.
So far, most
research has focused
on the
neurological decline associated with schizophrenia — typically involving a loss of brain tissue.
Funding was provided by the National Institute of
Neurological Disorders and Stroke, National Institute
on Drug Abuse, National Institute of General Medical Sciences, National Center for
Research Resources, Swiss National Science Foundations, and the State of California.
Sara Mole (UCL) discusses her work
on Batten disease, as well as the universal challenges encountered when
researching and treating rare
neurological diseases.
Support for this
research was provided by a Ruth L. Kirschstein Fellowship, the National Institute of
Neurological Disease and Stroke, the National Institute
on Aging and the Keck Foundation.
The National Institute of
Neurological Disorders and Stroke is the nation's primary funder of
research on the brain and nervous system.
«Our
research on BBB disruption and the role certain proteins play in neuro - inflammation has advanced our efforts to explore unexpected culprits in
neurological diseases,» Akassoglou said.
Gladstone Investigator Ken Nakamura, MD, PhD, and the National Institutes of Health Investigator Mark Cookson, PhD, also participated in this
research, which was supported by the following: the de Clercq Family, the National Center for Research Resources (#RR189288), the Burroughs - Wellcome Medical Scientist Fund, the National Institute of Neurological Disorders and Stroke (#P30NS069496), the National Institute on Aging, the Taube - Koret Center for Huntington's Disease Research, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 N
research, which was supported by the following: the de Clercq Family, the National Center for
Research Resources (#RR189288), the Burroughs - Wellcome Medical Scientist Fund, the National Institute of Neurological Disorders and Stroke (#P30NS069496), the National Institute on Aging, the Taube - Koret Center for Huntington's Disease Research, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 N
Research Resources (#RR189288), the Burroughs - Wellcome Medical Scientist Fund, the National Institute of
Neurological Disorders and Stroke (#P30NS069496), the National Institute
on Aging, the Taube - Koret Center for Huntington's Disease
Research, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 N
Research, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 NS04549).
Building initially
on world - leading pre-clinical and clinical
research into epilepsy and motor neurone disease, the FutureNeuro Centre is a scalable platform that will expand quickly to focus
on other chronic and rare
neurological diseases.
«Gladstone is uniquely qualified to take
on this major
research, which will fill a critical gap in the understanding of brain function and
neurological disease,» said Gladstone president Robert W. Mahley, MD, PhD.
It conducts, fosters, coordinates, and guides
research on the causes, prevention, diagnosis, and treatment of
neurological disorders and stroke, and supports basic
research in related scientific areas.
Katerina Akassoglou's
research on the brain's vascular and immune systems has led to new insights about multiple sclerosis and other
neurological conditions.
«Because of this, the Core promotes interdisciplinary and translational
research in behavioral neuroscience
on a much broader scale, bringing researchers closer to better treatments for
neurological and psychiatric diseases.»
«Our
research on the role of blood proteins in brain functions has identified new targets for therapeutic intervention in multiple sclerosis and other
neurological diseases,» said Dr. Akassoglou.
At the Gladstone Institutes, neuroscientists rely
on the Behavioral Core to
research brain functions in both healthy and disease states, investigating the causes of
neurological disorders and creating new therapies to overcome them.
Funding was provided by the National Institute
on Aging, the National Institute of
Neurological Disorders and Stroke, a National Institutes of Health Extramural
Research Facilities Improvement Program Project, the Larry L. Hillblom Foundation, the Hellman Family Foundation, the Taube / Koret Center for Neurodegenerative Diseases, the American Federation for Aging
Research, and the McKnight Endowment Fund for Neuroscience.
Funding was provided by the National Institute of
Neurological Disorders and Stroke, the National Institute
on Aging, the American Federation of Aging
Research (AFAR), a MetLife / AFAR Award, and gifts from the S.D. Bechtel, Jr..
Phenome — Since the first publication
on the BXDs, well over 200
research groups have generated behavioral,
neurological, pharmacological, immunological, and more recently, metabolic phenotypes for this family.